Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program (LC-FAOD DMP)

NCT04632953 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.

NCT NCT04632953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04632953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program (LC-FAOD DMP)
Lead sponsor
Ultragenyx Pharmaceutical Inc
Phase
Observational
Overall status
Active, not recruiting
Start date
November 30, 2021
Completion date
December 31, 2035
Enrollment
150 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

long-chain fatty acid oxidation disorders (lc-faod)